SSA
EDIT icon

Schonfeld Strategic Advisors’s Editas Medicine EDIT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,153
Closed -$52.1K – 2129
2024
Q2 		$52.1K Buy
+11,153
New +$62.9K ﹤0.01% 1929
2023
Q1 		– Sell
-73,800
Closed -$655K – 2218
2022
Q4 		$655K Sell
73,800
-139,502
-65% -$1.53M 0.01% 1370
2022
Q3 		$2.61M Buy
213,302
+26,458
+14% +$412K 0.02% 760
2022
Q2 		$2.21M Buy
+186,844
New +$2.5M 0.02% 717
2018
Q2 		– Sell
-21,466
Closed -$711K – 812
2018
Q1 		$711K Buy
+21,466
New +$765K 0.05% 399
2017
Q2 		– Sell
-10,858
Closed -$242K – 647
2017
Q1 		$242K Buy
+10,858
New +$225K 0.02% 512
2016
Q4 		– Sell
-13,982
Closed -$189K – 570
2016
Q3 		$189K Sell
13,982
-330
-2% -$6.76K 0.03% 366
2016
Q2 		$349K Buy
14,312
+4,586
+47% +$155K 0.08% 289
2016
Q1 		$336K Buy
+9,726
New +$256K 0.14% 202

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's EDIT Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 11,153 shares — an estimated $52.1K sold.

Schonfeld Strategic Advisors first reported a position in EDIT in Q1 2016 and held it in 9 quarters. The position peaked at $2.61M in Q3 2022. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,153 Editas Medicine shares in Q3 2024, an estimated $52.1K.
  • Schonfeld Strategic Advisors first reported a position in Editas Medicine in Q1 2016 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Editas Medicine position peaked at $2.61M in Q3 2022.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.